THE MODERN BIO← Home

MODERN BIO / CURRENT SAFETY & REGULATORY WATCH

UPDATED AUGUST 26, 2026

Safety alerts,
without the noise.

Exact products. Exact identifiers. Primary sources.

We separate recalls and regulatory facts from evidence, emerging technology and marketing—so you can see what changed and what it actually means.

2 ACTIVE RECALLS1 DEVICE WATCH

HOW TO USE THIS PAGE

Match the product first.
Then contact the right person.

A recall applies to the product, lot, strength and expiration listed in its notice—not automatically to every product in the same category. If you think you have an affected product, verify its label and contact the dispensing pharmacy, manufacturer or clinician for guidance.

01 / CURRENT RECALLS

What changed—and
who needs to check.

FDA PUBLISH DATEAUG 24
2026HIGH PRIORITY

FDA-POSTED COMPANY RECALL / PRESCRIPTION DRUG

Vitruvias Thyroid Tablets USP 30 mg

Vitruvias Therapeutics voluntarily recalled one lot after testing confirmed the potential for the tablets to be superpotent. The FDA notice says excess thyroid hormone can cause hyperthyroid symptoms and may create greater risk for older adults, pregnant patients and infants.

LOT
504950
EXPIRATION
9/30/2026
NDC
69680-166-00
REASON
Potential superpotency
WHAT TO DO

Check the manufacturer, strength, lot and expiration on the bottle. If they match, contact the dispensing pharmacy or prescribing clinician. The recall notice specifically says patients should not discontinue the medicine without contacting their healthcare provider for guidance or a replacement prescription.

What we know: No adverse events known to be related to this recall had been reported to Vitruvias when the notice was posted. That does not change the need to verify affected bottles.

Read the thyroid guide →Open the FDA notice ↗
FDA PUBLISH DATEAUG 20
2026HIGH PRIORITY

FDA-POSTED COMPANY RECALL / COMPOUNDED INJECTABLE

Optimal Balance Pharmacy compounded glutathione injection

Optimal Balance Pharmacy voluntarily recalled one lot of compounded glutathione after pharmacy testing identified elevated bacterial endotoxin. The affected product was distributed to consumers in multiple states, including Florida.

STRENGTH
200 mg/mL
PACKAGE
30 mL multi-dose vial
LOT
LG342009076
EXPIRATION
10/4/2026
WHAT THE RECALL SAYS

The company recall posted by FDA directs affected patients to stop using and quarantine the recalled product, contact Optimal Balance Pharmacy for retrieval, and contact the prescribing clinician if symptoms or problems may be related to its use.

Reported reactions: Fever, chills, severe headache, nausea, vomiting, pain and symptoms consistent with an allergic reaction. The notice also describes potentially serious endotoxin-related risks. This is a specific product-lot recall—not evidence that every glutathione product is contaminated.

Open the FDA notice ↗

02 / DEVICE WATCH

A new category—
with a narrow purpose.

FDA AUTHORIZATIONAUG 25
2026

REGULATORY FACT / NOT A CONSUMER WELLNESS PICK

Abbott Libre Duo 10 Day

The first U.S. wearable authorized to continuously monitor both glucose and ketones.

FDA authorized the system for people age 2 and older living with diabetes. It measures glucose and ketones in interstitial fluid every minute during its 10-day wear period and can provide alerts when ketones reach a concerning threshold.

  • It is designed around diabetes safety and earlier recognition of rising ketones that may precede diabetic ketoacidosis.
  • FDA says ketone information should be interpreted alongside glucose readings and symptoms.
  • It is not the same product category or use case as Abbott Lingo or Dexcom Stelo, which appear in our OTC wellness-CGM guide.
  • U.S. consumer pricing and launch availability were not provided in the FDA announcement reviewed for this update.
Compare OTC CGMs →Open the FDA authorization ↗

THE MODERN BIO STANDARD

Regulatory facts are not product endorsements.

This page is educational and does not replace product labeling, recall instructions, diagnosis or individualized medical care. If a product identifier matches—or if you have concerning symptoms—contact the appropriate pharmacy, manufacturer or qualified clinician. Seek urgent care for potentially serious symptoms.